TABLE 2.
Mutations in the gyrA QRDR of C. jejuni isolates and MICs of nalidixic acid and ciprofloxacin
| Isolate no. | State health department of origin |
gyrA mutation resulting in substitution at:
|
MIC of:
|
||
|---|---|---|---|---|---|
| Amino acid no. 86a | Amino acid no. 104b | Nalidixic acid | Ciprofloxacin | ||
| D125 | No | No | 4 | 0.06 | |
| D133c | No | No | 8 | 0.125 | |
| D135 | No | No | 4 | 0.06 | |
| D2295d | No | No | 4 | 0.03 | |
| D2589 | No | No | 8 | 0.125 | |
| D3820 | No | No | 8 | 0.125 | |
| D3836 | No | No | 8 | 0.06 | |
| D4344e | Yes | No | 256 | 8 | |
| CS7 | Oreg. | No | No | 16 | 0.25 |
| CS10 | Conn. | No | No | 16 | 0.25 |
| CS17 | Calif. | No | No | 16 | 0.25 |
| CS18 | Oreg. | No | No | 8 | 0.125 |
| CS54 | Minn. | No | No | 8 | 0.25 |
| CS57 | Conn. | No | No | 16 | 0.25 |
| CS58 | Conn. | No | No | 8 | 0.125 |
| CS59 | Conn. | No | No | 8 | 0.125 |
| CS61 | Conn. | No | No | 8 | 0.125 |
| CS64 | Conn. | No | No | 16 | 0.25 |
| CS89 | Calif. | No | No | 8 | 0.125 |
| CS120 | Minn. | No | No | 8 | 0.06 |
| CS133 | Ga. | No | No | 4 | 0.125 |
| CS5 | Oreg. | Yes | No | 512 | 4 |
| CS8 | Conn. | Yes | No | 512 | 32 |
| CS34 | Minn. | Yes | No | 512 | 32 |
| CS40 | Minn. | Yes | No | 512 | 8 |
| CS42 | Minn. | Yes | No | 512 | 32 |
| CS50 | Calif. | Yes | Yes | 256 | 16 |
| CS71 | Oreg. | Yes | No | 512 | 8 |
| CS82 | Conn. | Yes | No | 512 | 8 |
| CS143 | Calif. | Yes | No | 512 | 16 |
| CS161 | Ga. | Yes | No | 512 | 32 |
| CS165 | Ga. | Yes | No | 512 | 32 |
| CS166 | Ga. | Yes | No | 256 | 8 |
Mutants had a Thr-86-to-Ile (ACA-to-ATA) substitution.
One mutant had a Pro-104-to-Ser (CCA-to-TCA) substitution.
C. jejuni subsp. jejuni ATCC 33560.
C. jejuni subsp. doylei ATCC 49349.
CDC C. jejuni isolate from 1992.